Akanda Corp. (AKAN)
NASDAQ: AKAN · IEX Real-Time Price · USD
2.000
-0.140 (-6.54%)
At close: Jul 19, 2024, 4:00 PM
2.050
+0.050 (2.50%)
Pre-market: Jul 22, 2024, 7:15 AM EDT
Company Description
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products for medicinal use worldwide.
It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Akanda Corp.
| Country | United Kingdom |
| Founded | 2021 |
| IPO Date | Mar 15, 2022 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 46 |
| CEO | Ms. Katharyn Field |
Contact Details
Address: 1a, 1b Learoyd Road New Romney, X0 TN28 8XU United Kingdom | |
| Phone | 442034889514 |
| Website | akandacorp.com |
Stock Details
| Ticker Symbol | AKAN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001888014 |
| CUSIP Number | 00971M106 |
| ISIN Number | CA00971M2058 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Katharyn Field | Interim Chief Executive Officer and Executive Director |
| Dr. Gurcharn Deol B.A., M.A., Ph.D. | Chief Financial Officer |
| Thomas Flow | Chief Operating Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 14, 2024 | 6-K | Report of foreign issuer |
| Jun 12, 2024 | 6-K | Report of foreign issuer |
| May 23, 2024 | 6-K | Report of foreign issuer |
| May 20, 2024 | 6-K | Report of foreign issuer |
| May 20, 2024 | 424B5 | Filing |
| May 17, 2024 | 424B5 | Filing |
| May 17, 2024 | 6-K | Report of foreign issuer |
| May 16, 2024 | 6-K | Report of foreign issuer |
| May 14, 2024 | 6-K | Report of foreign issuer |
| May 13, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |